Shenzhen Yilian Technology Limited Company and Shenzhen Jialian Private Equity Investment Fund Management Co., Ltd. won the auction to acquire 8.67% stake in Shandong Sinobioway Biomedicine Co., Ltd. from Beijing Sinobioway Group Co., Ltd. for CNY 77.85 million.
June 01, 2022
Share
Shenzhen Yilian Technology Limited Company and Shenzhen Jialian Private Equity Investment Fund Management Co., Ltd. won the auction to acquire 8.67% stake in Shandong Sinobioway Biomedicine Co., Ltd. (SZSE:002581) from Beijing Sinobioway Group Co., Ltd. for CNY 77.85 million on May 26, 2022. As per the transaction, Shenzhen Yilian Technology Limited Company and Shenzhen Jialian Private Equity Investment Fund Management Co., Ltd. will acquire 57.2 million shares.
Shandong Sinobioway Biomedicine Co Ltd, formerly Zibo Wanchang Science & Technology Co Ltd, is a China-based company principally engaged in the manufacturing of pharmaceuticals. The Company is engaged in the business of interferon, nerve growth factor, biopharmaceutical contract research organization (CRO)/pharmaceutical contract development and manufacturing enterprise (CDMO), vaccines and pharmaceutical intermediates. The Company's main products include anferon, encyclopedia, Corona Virus Disease2019 vaccine and others. The Company distributes its products within domestic market.
Shenzhen Yilian Technology Limited Company and Shenzhen Jialian Private Equity Investment Fund Management Co., Ltd. won the auction to acquire 8.67% stake in Shandong Sinobioway Biomedicine Co., Ltd. from Beijing Sinobioway Group Co., Ltd. for CNY 77.85 million.
SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD. 
